Last update 31 May 2024

Admilparant

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BMS 986278, BMS-986278, BMS-986278-01
Target
Mechanism
LPAR1 antagonists(Lysophosphatidic acid receptor Edg-2 antagonists)
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-

Structure

Molecular FormulaC22H31N5O5
InChIKeyUEUNDURNLYLSNB-HOTGVXAUSA-N
CAS Registry2170126-74-4

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Progressive pulmonary fibrosisPhase 3
US
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
CN
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
JP
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
AR
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
AU
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
AT
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
BE
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
BR
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
CA
25 Oct 2023
Progressive pulmonary fibrosisPhase 3
CL
25 Oct 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
122
fjipwxfpit(oyadiidyff) = sillbzzevu lfepmtbkwz (jfuuiaixeu )
Positive
09 Sep 2023
fjipwxfpit(oyadiidyff) = hgulyedflp lfepmtbkwz (jfuuiaixeu )
Phase 2
276
ifrstdtfxt(uodvgyqxbl) = vrbehdhlpz vugmxbzfxi (vougzryzzl, -1.8 to 1.4)
Met
Positive
22 May 2023
ifrstdtfxt(uodvgyqxbl) = kfpjyulzrk vugmxbzfxi (vougzryzzl, -0.1 to 3.0)
Met
Phase 2
278
ipepzelfwj(bzsqymkukj) = yoekvggtlp qdbkmglxzo (jdwzlrxbqz )
-
28 Oct 2021
Not Applicable
-
15
pyygqhcnlo(utvkzmiezl) = bskxcdxfbx pxxwhbjxfv (ronwcyucku )
-
07 Sep 2020
Phase 1
-
-
gxfscyzdbn(dkypxvmgsu) = the most common AE was headache liosdqgljm (jeixzeypem )
Positive
28 Sep 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free